Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, BrightSpring Health Services Inc’s stock clocked out at $29.45, down -4.20% from its previous closing price of $30.74. In other words, the price has decreased by -$4.20 from its previous closing price. On the day, 4.18 million shares were traded. BTSG stock price reached its highest trading level at $30.89 during the session, while it also had its lowest trading level at $29.41.
Ratios:
To gain a deeper understanding of BTSG’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 74.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.27. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 1.76. In the meantime, Its Debt-to-Equity ratio is 1.56 whereas as Long-Term Debt/Eq ratio is at 1.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, TD Cowen on June 23, 2025, initiated with a Buy rating and assigned the stock a target price of $37.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 14 ’25 when McMaude Michael A bought 16,168 shares for $22.40 per share.
KKR Group Partnership L.P. sold 2,100,000 shares of BTSG for $44,418,990 on Jun 24 ’25. The 10% Owner now owns 77,096,337 shares after completing the transaction at $21.15 per share. On Jun 24 ’25, another insider, KKR Phoenix Aggregator L.P., who serves as the 10% Owner of the company, sold 2,100,000 shares for $21.15 each. As a result, the insider received 44,418,990 and left with 77,096,337 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTSG now has a Market Capitalization of 5217029120 and an Enterprise Value of 8629839872. As of this moment, BrightSpring’s Price-to-Earnings (P/E) ratio for their current fiscal year is 99.63, and their Forward P/E ratio for the next fiscal year is 23.51. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.44 while its Price-to-Book (P/B) ratio in mrq is 2.99. Its current Enterprise Value per Revenue stands at 0.687 whereas that against EBITDA is 14.337.
Stock Price History:
The Beta on a monthly basis for BTSG is 2.40, which has changed by 0.8111931 over the last 52 weeks, in comparison to a change of 0.13033986 over the same period for the S&P500. Over the past 52 weeks, BTSG has reached a high of $31.95, while it has fallen to a 52-week low of $14.73. The 50-Day Moving Average of the stock is 13.24%, while the 200-Day Moving Average is calculated to be 35.62%.
Shares Statistics:
It appears that BTSG traded 3.08M shares on average per day over the past three months and 4285950 shares per day over the past ten days. A total of 177.06M shares are outstanding, with a floating share count of 97.61M. Insiders hold about 44.90% of the company’s shares, while institutions hold 71.96% stake in the company. Shares short for BTSG as of 1759190400 were 16305611 with a Short Ratio of 5.30, compared to 1756425600 on 15897990. Therefore, it implies a Short% of Shares Outstanding of 16305611 and a Short% of Float of 29.209998.
Earnings Estimates
The dynamic stock of BrightSpring Health Services Inc (BTSG) is currently attracting attention from 11.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.31, with high estimates of $0.46 and low estimates of $0.19.
Analysts are recommending an EPS of between $1.29 and $0.75 for the fiscal current year, implying an average EPS of $0.97. EPS for the following year is $1.2, with 12.0 analysts recommending between $1.64 and $0.78.
Revenue Estimates
In. The current quarter, 11 analysts expect revenue to total $3.17B. It ranges from a high estimate of $3.21B to a low estimate of $3.07B. As of. The current estimate, BrightSpring Health Services Inc’s year-ago sales were $2.91BFor the next quarter, 11 analysts are estimating revenue of $3.32B. There is a high estimate of $3.41B for the next quarter, whereas the lowest estimate is $3.21B.
A total of 13 analysts have provided revenue estimates for BTSG’s current fiscal year. The highest revenue estimate was $12.65B, while the lowest revenue estimate was $12.42B, resulting in an average revenue estimate of $12.51B. In the same quarter a year ago, actual revenue was $11.27BBased on 12 analysts’ estimates, the company’s revenue will be $14.1B in the next fiscal year. The high estimate is $14.77B and the low estimate is $13.45B.
